Skip to content

Careers
Contact us

Our Company
Pipeline & Programs
Our Approach
News & Events

FR
EN

Home
Our Company
Pipeline & Programs
Our Approach
News & Events
Careers
Contact us
Terms and Conditions
Privacy Policy

News
& Events

News
& Events

News
& Events

Previous
1
…
10
11
12

Oct 28, 2015 National Institutes of Health Notice on Prospective Grant of Exclusive License.

Previous
1
…
10
11
12

Our Company
Pipeline & Programs
Our Approach
News & Events
Contact us
Careers

© Inversago 2023

Terms and Conditions
Privacy Policy

Effective 08 September 2023,
Inversago Pharma is a wholly-owned subsidiary
of Novo Nordisk A/S

Click for
PRESS RELEASE
Click to visit
NOVONORDISK.COM

Voir la version française